Norbert W. Bischofberger

2015

In 2015, Norbert W. Bischofberger earned a total compensation of $7M as Executive Vice President, Research and Development and Chief Scientific Officer at Gilead Sciences, a 2% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$1,275,000
Option Awards$2,099,904
Salary$994,231
Stock Awards$2,576,436
Other$7,500
Total$6,953,071

Bischofberger received $2.6M in stock awards, accounting for 37% of the total pay in 2015.

Bischofberger also received $1.3M in non-equity incentive plan, $2.1M in option awards, $994.2K in salary and $7.5K in other compensation.

Rankings

In 2015, Norbert W. Bischofberger's compensation ranked 990th out of 13,638 executives tracked by ExecPay. In other words, Bischofberger earned more than 92.7% of executives.

ClassificationRankingPercentile
All
990
out of 13,638
93rd
Division
Manufacturing
349
out of 5,187
93rd
Major group
Chemicals And Allied Products
126
out of 1,857
93rd
Industry group
Drugs
95
out of 1,531
94th
Industry
Biological Products, Except Diagnostic Substances
14
out of 260
95th
Source: SEC filing on March 28, 2016.

Bischofberger's colleagues

We found four more compensation records of executives who worked with Norbert W. Bischofberger at Gilead Sciences in 2015.

2015

John Martin

Gilead Sciences

Chief Executive Officer

2015

John Milligan

Gilead Sciences

Chief Operating Officer

2015

Gregg Alton

Gilead Sciences

Executive Vice President, Corporate and Medical Affairs

2015

Robin Washington

Gilead Sciences

Chief Financial Officer

You may also like